Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Sickling disorders

In nephrogenic diabetes insipidus the kidney s ability to respond to AVP is impaired by different causes, such as drugs (e.g. lithium), chronic disorders (e.g. sickle cell disease, kidney failure) or inherited genetic disorders (X-linked or autosomal NDI). This type of diabetes insipidus can not be treated by exogenous administration of AVP or AVP analogues. Instead, diuretics (hydrochlorothiazide combined or not with amiloride) and NSAI (indomethacin) are administrated to ameliorate polyuria. [Pg.821]

The detection of restriction fi agment length polymorphisms (RFLPs) facilitates prenatal detection of hereditary disorders such as sickle cell trait, beta-thalassemia, infant phenylketonuria, and Huntington s disease. Detection of RFLPs involves cleavage of double-stranded DNA by restriction endonucleases, which can detect subtle alterations in DNA that affect their recognized sites. Chapter 40 provides further details concerning the use of PCR and restriction enzymes for diagnosis. [Pg.57]

Onset of action is slow at around 30 minutes, which limits spontaneity. In addition, patients and partners may complain of a cold, lifeless, discolored penis that has a hinge-like feel. Painful ejaculation or inability to ejaculate are additional adverse effects. VEDs are contraindicated in persons with sickle cell disease and should be used with caution in patients on oral anticoagulants or who have bleeding disorders due to the increased possibility of priapism. [Pg.783]

O Sickle cell disease is an inherited disorder caused by a defect in the gene for hemoglobin. Patients may have one defective gene (sickle cell trait) or two defective genes (sickle cell disease). [Pg.1003]

Sickle cells were first identified by physician James Herrick in a 20-year-old medical student from Grenada in 1910.1 O Sickle cell syndrome refers to a collection of autosomal recessive genetic disorders that are characterized by the presence of at least one sickle hemoglobin gene (HbS).2,3... [Pg.1003]

The 23-valent pneumococcal polysaccharide vaccine is recommended for use in all adults 65 years of age or older and adults less than 65 years who have medical comorbidities that increase the risk for serious complications from S. pneumoniae infection, such as chronic pulmonary disorders, cardiovascular disease, diabetes mellitus, chronic liver disease, chronic renal failure, functional or anatomic asplenia, and immunosuppressive disorders. Alaskan natives and certain Native American populations are also at increased risk. Children over the age of 2 years may be vaccinated with the 23-valent pneumococcal polysaccharide vaccine if they are at increased risk for invasive S. pneumoniae infections, such as children with sickle cell anemia or those receiving cochlear implants. [Pg.1245]

Sickle-cell syndrome A group of autosomal recessive genetic disorders characterized by the presence of at least one sickle-hemoglobin gene. [Pg.1576]

Hydroxy urea (HU), a hydroxylated derivative of urea, has long been used in the treatment of various forms of neoplastic disorders such as polycythemia vera, head and neck cancer, chronic granulocytic leukemia, and more recently in sickle cell disease, / thalassemia and HIV infection [1],... [Pg.235]

Since HU needs to be taken lifelong in the treatment of non-neoplastic conditions such as SCA (since the inhibition of ribonucleotide reductase is reversible) a major concern is its long term secondary effects. Several studies have shown the potential leukomegenic effect of HU in myeloproliferative disorders [22], [23]. Such concern becomes quite legitimate in sickle cell patients with permanently expanded erythropoiesis in whom the use of HU is at the limit of marrow toxicity. Hence alternative therapies must be sought for. [Pg.239]

Klug PP, Kaye N, Jensen WN. Endothelial cell and vascular damage in the sickle cell disorders. Blood Cells 1982 8 175-184. [Pg.248]

Sickle cell syndromes are hereditary disorders characterized by the presence of sickle hemoglobin (HbS) in red blood cells (RBCs). [Pg.384]

Intracavernosal injection therapy should be used cautiously in patients at risk of priapism (e.g., sickle cell disease or lymphoproliferative disorders) and bleeding complications secondary to injections. [Pg.956]

Pi Z = 2 Dx = 1.452 R = 0.066 for 2,097 intensities. The carbon chain has a sickle conformation, being cis with respect to the double bond. The carbon and oxygen atoms lie in two planes, with C-2-C-3-C-4-C-5 = +71°. One of the carboxyl groups is eclipsed to the C-C bonds, with 0-l=C-l-C-2—C-3 = + 1°, and the other is so inclined that 0-5=C-5-C-4-C-3 = +22°. The carboxyl groups are hydrogen bonded to afford dimers, with one of the hydrogen atoms disordered. [Pg.422]

One or more major signs or symptoms of the disorder (for example, sickle cell anemia)... [Pg.27]

A family medical history can identify people with a higher-than-usual chance of having common disorders, such as heart disease, high blood pressure, stroke, certain cancers, and diabetes. These complex disorders are influenced by a combination of genetic factors, environmental conditions, and lifestyle choices. A family history also can provide information about the risk of rarer conditions caused by mutations in a single gene, such as cystic fibrosis and sickle cell anemia. [Pg.30]

Examples of genetic conditions that are more common in particular ethnic groups are sickle cell anemia, which is more common in people of African, African-American, or Mediterranean heritage and Tay-Sachs disease, which is more likely to occur among people of Ashkenazi (eastern and central European) Jewish or French Canadian ancestry. It is important to note, however, that these disorders can occur in any ethnic group. [Pg.36]

Sickle cell disease is an autosoinal recessive disorder seen in approximately 1/600 African American births. It is even more common in some parts of Africa, vrftere up to 1/50 live births are affected. [Pg.303]


See other pages where Sickling disorders is mentioned: [Pg.199]    [Pg.252]    [Pg.668]    [Pg.199]    [Pg.252]    [Pg.668]    [Pg.1150]    [Pg.1150]    [Pg.1119]    [Pg.1]    [Pg.70]    [Pg.205]    [Pg.1003]    [Pg.1576]    [Pg.334]    [Pg.236]    [Pg.236]    [Pg.439]    [Pg.678]    [Pg.82]    [Pg.326]    [Pg.40]    [Pg.41]    [Pg.54]    [Pg.26]    [Pg.366]    [Pg.221]    [Pg.388]    [Pg.99]    [Pg.250]   
See also in sourсe #XX -- [ Pg.668 ]




SEARCH



Blood disorder sickle cell

Genetic disorders sickle cell disease

Hematologic disorder sickle cell

Hemoglobin S and Sickling Disorders

Sickle

© 2024 chempedia.info